5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Zygosity, lineage, and penetrance dictate the role of germline pathogenicity in tumorigenesis
    Meeting Abstract

    Bandlamudi, C.; Srinivasan, P.; Jonsson, P.; Kemel, Y. M.; Chavan, S. S.; Richards, A. L.; Penson, A.; Bielski, C. M.; Fong, C.; Syed, A.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis
    Meeting Abstract

    Bolton, K.; Ptashkin, R.; Braunstein, L.; Gao, T.; Devlin, S. M.; Kelly, D.; Coombs, C.; Patel, M.; Moarii, M.; Bernard, E.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A Phase Ib/IIa study of the BET bromodomain inhibitor ZEN-3694 in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Aggarwal, R.; Abida, W.; Schweizer, M.; Pantuck, A.; Nanus, D.; Heath, E.; Lakhotia, S.; Hansen, H.; Silverman, M.; Bauman, L.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Aneuploidy drives lethal progression in prostate cancer
    Meeting Abstract

    Stopsack, K. H.; Whittaker, C. A.; Gerke, T. A.; Loda, M.; Kantoff, P. W.; Mucci, L. A.; Amon, A.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Pharmacokinetic modeling of serum platinum reveals extent of long-term exposure and associated comorbidities after cisplatin treatment
    Meeting Abstract

    Trendowski, M. R.; El-Charif, O.; Mu, Z.; Ratain, M. J.; Wheeler, H.; Dinh, P. C.; Feldman, D. R.; Ardeshir-Rouhani-Fard, S.; Hamilton, R. J.; Vaughn, D. J.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A portable bioinformatics pipeline for the FDA authorized IMPACT DNAseq assay
    Meeting Abstract

    Tang, Z.; Kumar, N.; Bolipata, A.; Song, T.; Kandoth, C.; Liu, F.; McManamon, D.; Hampton, O.; Socci, N.; Solit, D.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Dissecting the role of zygosity and lineage in Lynch syndrome-associated microsatellite instability
    Meeting Abstract

    Srinivasan, P.; Bandlamudi, C.; Shia, J.; Latham, A. S.; Jonsson, P.; Penson, A.; Middha, S.; Hechtman, J.; Zehir, A.; Richards, A.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Hypermethylation of miR193b reactivates master drivers of the poor prognosis prostate cancer
    Meeting Abstract

    Mazzu, Y. Z.; Yoshikawa, Y.; Nandakumar, S.; Armenia, J.; Jehane, L.; Lee, G. S.; Chakraborty, G.; Kantoff, P.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Molecular screening of patients with FGFR alterations for phase 1 (ph1) study with the selective FGFR inhibitor Debio 1347
    Meeting Abstract

    Iafrate, A. J.; Borger, D. R.; Vivancos, A.; Voss, M.; Cleary, J.; Meric-Bernstam, F.; Tabernero, J.; Flaherty, K.; Ishii, N.; Brichory, F.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A comparative analysis of fraction genome altered vs tumor mutational count in prostate cancer
    Meeting Abstract

    Chakraborty, G.; Atiq, M.; Nandakumar, S.; Mazzu, Y. Z.; Armenia, J.; Yoshikawa, Y.; Khan, N.; Lee, G. S. M.; Mucci, L.; Kantoff, P. W.
    Cancer Research (2019)

    Fulltext@MSK | Save